Hepatocellular carcinoma after a sustained virological response by direct‐acting antivirals harbors TP53 inactivation

Hepatocellular carcinoma after a sustained virological response by direct‐acting antivirals harbors TP53 inactivation

Abstract Introduction The genomic characteristics of hepatocellular carcinoma (HCC) after a sustained virological response (SVR) and its differences according to whether an SVR was achieved by treatment with direct‐acting antivirals (DAA) or interferon (IFN) are still not fully understood. Methods S...

Full description

Bibliographic Details
Main Authors: Taisuke Imamura, Yukiyasu Okamura, Keiichi Ohshima, Katsuhiko Uesaka, Teiichi Sugiura, Takaaki Ito, Yusuke Yamamoto, Ryo Ashida, Katsuhisa Ohgi, Shimpei Otsuka, Sumiko Ohnami, Takeshi Nagashima, Keiichi Hatakeyama, Yuko Kakuda, Takashi Sugino, Kenichi Urakami, Yasuto Akiyama, Ken Yamaguchi
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:Cancer Medicine
Subjects:
direct‐acting antiviral agent
hepatitis C virus
hepatocellular carcinoma
interferon
sustained virological response
Online Access:https://doi.org/10.1002/cam4.4571

Internet

https://doi.org/10.1002/cam4.4571

Similar Items